Invega Sustenna®(For medical professional reference only)
Trade name
Generic name
Appearance
Indication
The product is used for the treatment of schizophrenia in the acute and maintenance phases.
Collaborating in more than 150 countries.
By clicking on a link below, you may enter a different part of this website, or a website outside of Janssen.com. These sections or websites are governed by their own Legal and Privacy Policies.
The product is used for the treatment of schizophrenia in the acute and maintenance phases.